Repetitive Transcranial Magnetic Stimulation Target Location Methods for Depression

Overview

Journal Front Neurosci

Date 2021 Sep 27

PMID 34566561

Citations 10

Authors

Min Zhang

Runhua Wang

Xin Luo

Si Zhang

Xiaomei Zhong

Yuping Ning

Bin Zhang

Affiliations

Soon will be listed here.

Abstract

Major depressive disorder (MDD) is a substantial global public health problem in need of novel and effective treatment strategies. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and promising treatment for depression that has been approved by the U.S. Food and Drug Administration (FDA). However, the methodological weaknesses of existing work impairs the universal clinical use of rTMS. The variation of stimulated targets across the dorsolateral prefrontal cortex may account for most of the heterogeneity in the efficacy of rTMS. Many rTMS target location methods for MDD have been developed in recent decades. This review was conducted to assess this emerging field and to improve treatment outcomes in clinical practice.

Citing Articles

MAGNITUDE: Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive-Compulsive Disorder: A Randomized Sham-Controlled Phase II Trial Protocol.

Rech L, Vivanco R, Guersoni A, Ninapaytan G, Rivera P, Ramos-Orosco E Brain Sci. 2025; 15(2).

PMID: 40002439 PMC: 11853550. DOI: 10.3390/brainsci15020106.

Targeting VMPFC-amygdala circuit with TMS in substance use disorder: A mechanistic framework.

Soleimani G, Conelea C, Kuplicki R, Opitz A, Lim K, Paulus M Addict Biol. 2025; 30(1):e70011.

PMID: 39783881 PMC: 11714170. DOI: 10.1111/adb.70011.

Engineering and Technological Advancements in Repetitive Transcranial Magnetic Stimulation (rTMS): A Five-Year Review.

Tubbs A, Vazquez E Brain Sci. 2024; 14(11).

PMID: 39595855 PMC: 11591941. DOI: 10.3390/brainsci14111092.

Reproducible routes: reliably navigating the connectome to enrich personalized brain stimulation strategies.

Liu Y, Sundman M, Ugonna C, Chen Y, Green J, Haaheim L Front Hum Neurosci. 2024; 18:1477049.

PMID: 39568548 PMC: 11576443. DOI: 10.3389/fnhum.2024.1477049.

Pilot Study of Personalized Transcranial Magnetic Stimulation with Spectral Electroencephalogram Analyses for Assessing and Treating Persons with Autism.

Makale M, Nybo C, Blum K, Dennen C, Elman I, Murphy K J Pers Med. 2024; 14(8).

PMID: 39202048 PMC: 11355711. DOI: 10.3390/jpm14080857.

References

Li C, Su T, Wang S, Tu P, Hsieh J . Prefrontal glucose metabolism in medication-resistant major depression. Br J Psychiatry. 2015; 206(4):316-23. DOI: 10.1192/bjp.bp.113.140434. View

Cash R, Weigand A, Zalesky A, Siddiqi S, Downar J, Fitzgerald P . Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression. Biol Psychiatry. 2020; 90(10):689-700. DOI: 10.1016/j.biopsych.2020.05.033. View

George M, Taylor J, Short E . The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry. 2012; 26(1):13-8. PMC: 4214363. DOI: 10.1097/YCO.0b013e32835ab46d. View

George M, Padberg F, Schlaepfer T, OReardon J, Fitzgerald P, Nahas Z . Controversy: Repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress.... Brain Stimul. 2010; 2(1):14-21. DOI: 10.1016/j.brs.2008.06.001. View

Voigt J, Leuchter A, Carpenter L . Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis. Transl Psychiatry. 2021; 11(1):330. PMC: 8163818. DOI: 10.1038/s41398-021-01441-4. View

Rogers M, Kasai K, Koji M, Fukuda R, Iwanami A, Nakagome K . Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res. 2004; 50(1):1-11. DOI: 10.1016/j.neures.2004.05.003. View

Weigand A, Horn A, Caballero R, Cooke D, Stern A, Taylor S . Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites. Biol Psychiatry. 2017; 84(1):28-37. PMC: 6091227. DOI: 10.1016/j.biopsych.2017.10.028. View

Levkovitz Y, Isserles M, Padberg F, Lisanby S, Bystritsky A, Xia G . Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry. 2015; 14(1):64-73. PMC: 4329899. DOI: 10.1002/wps.20199. View

Singh A, Erwin-Grabner T, Sutcliffe G, Antal A, Paulus W, Goya-Maldonado R . Personalized repetitive transcranial magnetic stimulation temporarily alters default mode network in healthy subjects. Sci Rep. 2019; 9(1):5631. PMC: 6449366. DOI: 10.1038/s41598-019-42067-3. View

10.

Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C . Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry. 2001; 50(1):58-61. DOI: 10.1016/s0006-3223(01)01153-2. View

11.

Zhou M, Hu X, Lu L, Zhang L, Chen L, Gong Q . Intrinsic cerebral activity at resting state in adults with major depressive disorder: A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 75:157-164. DOI: 10.1016/j.pnpbp.2017.02.001. View

12.

Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View

13.

Brunoni A, Chaimani A, Moffa A, Razza L, Gattaz W, Daskalakis Z . Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis. JAMA Psychiatry. 2016; 74(2):143-152. DOI: 10.1001/jamapsychiatry.2016.3644. View

14.

Jing Y, Zhao N, Deng X, Feng Z, Huang G, Meng M . Pregenual or subgenual anterior cingulate cortex as potential effective region for brain stimulation of depression. Brain Behav. 2020; 10(4):e01591. PMC: 7177590. DOI: 10.1002/brb3.1591. View

15.

Fitzgerald P . Targeting repetitive transcranial magnetic stimulation in depression: do we really know what we are stimulating and how best to do it?. Brain Stimul. 2021; 14(3):730-736. DOI: 10.1016/j.brs.2021.04.018. View

16.

Liston C, Chen A, Zebley B, Drysdale A, Gordon R, Leuchter B . Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol Psychiatry. 2014; 76(7):517-26. PMC: 4209727. DOI: 10.1016/j.biopsych.2014.01.023. View

17.

OReardon J, Solvason H, Janicak P, Sampson S, Isenberg K, Nahas Z . Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007; 62(11):1208-16. DOI: 10.1016/j.biopsych.2007.01.018. View

18.

Siddiqi S, Taylor S, Cooke D, Pascual-Leone A, George M, Fox M . Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation. Am J Psychiatry. 2020; 177(5):435-446. PMC: 8396109. DOI: 10.1176/appi.ajp.2019.19090915. View

19.

Zhang T, Huang Y, Jin Y, Ma X, Liu Z . Treatment for Major Depressive Disorder by Repetitive Transcranial Magnetic Stimulation in Different Parameters: A Randomized Double-Blinded Controlled Trial. Front Psychiatry. 2021; 12:623765. PMC: 8055955. DOI: 10.3389/fpsyt.2021.623765. View

20.

Fitzgerald P, Maller J, Hoy K, Thomson R, Daskalakis Z . Exploring the optimal site for the localization of dorsolateral prefrontal cortex in brain stimulation experiments. Brain Stimul. 2010; 2(4):234-7. DOI: 10.1016/j.brs.2009.03.002. View